P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus.

Saved in:
Bibliographic Details
Title: P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus.
Authors: Faliti CE; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Gualtierotti R; Department of Clinical Science and Community Health, University of Milan, Milan, Italy.; Lupus Clinic, IASST-Istituto Gaetano Pini, Milan, Italy., Rottoli E; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy., Gerosa M; Department of Clinical Science and Community Health, University of Milan, Milan, Italy.; Lupus Clinic, IASST-Istituto Gaetano Pini, Milan, Italy., Perruzza L; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Romagnani A; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Pellegrini G; Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland., De Ponte Conti B; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy., Rossi RL; Istituto Nazionale Genetica Molecolare 'Romeo ed Enrica Invernizzi,' Milan, Italy., Idzko M; Division of Pulmonology, Department of Medicine II, Medical University of Vienna, Vienna, Austria., Mazza EMC; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy., Bicciato S; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy., Traggiai E; Novartis Institute for Biomedical Research, Basel, Switzerland., Meroni PL; Department of Clinical Science and Community Health, University of Milan, Milan, Italy pierluigi.meroni@unimi.it.; Lupus Clinic, IASST-Istituto Gaetano Pini, Milan, Italy.; Istituto Auxologico Italiano, Milan, Italy., Grassi F; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland fabio.grassi@irb.usi.ch.; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.; Istituto Nazionale Genetica Molecolare 'Romeo ed Enrica Invernizzi,' Milan, Italy.
Source: The Journal of experimental medicine [J Exp Med] 2019 Feb 04; Vol. 216 (2), pp. 317-336. Date of Electronic Publication: 2019 Jan 17.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20171976